Page last updated: 2024-08-24

irinotecan and epz-6438

irinotecan has been researched along with epz-6438 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Earley, E; Erickson, SW; Houghton, PJ; Kurmasheva, RT; Smith, MA	1

Other Studies

1 other study(ies) available for irinotecan and epz-6438

Article	Year
In vivo evaluation of the EZH2 inhibitor (EPZ011989) alone or in combination with standard of care cytotoxic agents against pediatric malignant rhabdoid tumor preclinical models-A report from the Pediatric Preclinical Testing Consortium. Pediatric blood & cancer, 2021, Volume: 68, Issue:2 Topics: Animals; Antineoplastic Agents; Benzamides; Biphenyl Compounds; Cell Line, Tumor; Cyclophosphamide; Drug Synergism; Enhancer of Zeste Homolog 2 Protein; Female; Humans; Irinotecan; Mice; Mice, SCID; Morpholines; Pyridones; Rhabdomyosarcoma; Vincristine; Xenograft Model Antitumor Assays	2021

Article

Year

In vivo evaluation of the EZH2 inhibitor (EPZ011989) alone or in combination with standard of care cytotoxic agents against pediatric malignant rhabdoid tumor preclinical models-A report from the Pediatric Preclinical Testing Consortium.

Pediatric blood & cancer, 2021, Volume: 68, Issue:2

Topics: Animals; Antineoplastic Agents; Benzamides; Biphenyl Compounds; Cell Line, Tumor; Cyclophosphamide; Drug Synergism; Enhancer of Zeste Homolog 2 Protein; Female; Humans; Irinotecan; Mice; Mice, SCID; Morpholines; Pyridones; Rhabdomyosarcoma; Vincristine; Xenograft Model Antitumor Assays

2021